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Abstract
Gene targeting protocols for mammalian cells remain inefficient and labor intensive. Here we describe FASTarget, a rapid,
fluorescent cell sorting based strategy to isolate rare gene targeting events in human somatic cells. A fluorescent protein is
used as a means for direct selection of targeted clones obviating the need for selection and outgrowth of drug resistant
clones. Importantly, the use of a promoter-less, ATG-less construct greatly facilitates the recovery of correctly targeted cells.
Using this method we report successful gene targeting in up to 94% of recovered human somatic cell clones. We create
functional EYFP-tagged knockin clones in both transformed and non-transformed human somatic cell lines providing a
valuable tool for mammalian cell biology. We further demonstrate the use of this technology to create gene knockouts.
Using this generally applicable strategy we can recover gene targeted clones within approximately one month from DNA
construct delivery to obtaining targeted monoclonal cell lines.
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Introduction
The ability to locally engineer mammalian genomes represents
an invaluable tool to advance mouse genetics, human molecular
and cellular biology as well as providing potential to treat genetic
defects. The most versatile methodology involves the direct
modification of endogenous sequences by gene targeting, allowing
either for deleting gene function (knockout) or for the alteration of
gene function (knockin). Gene targeting is achieved by providing
cells with exogenous DNA that harbor sequences homologous to
the genomic target locus resulting in the insertion of foreign
sequences or deletion of intervening sequences by homologous
recombination. Conventional gene targeting experiments in
mouse ES cells or human cell cultures typically require the
assembly of large targeting constructs, weeks of drug selection and
extensive PCR screening to identify rare recombinants. Targeting
frequencies using this methodology are on the order of 1–10 per
million transfected cells depending on the extent of homology
[1,2]. Recent advances in the use of zinc finger nuclease
technology (ZFN) have greatly improved targeting efficiencies.
However, construction of specific nucleases remains either labor
intensive or expensive [3–5]. In addition, nuclease expression can
be genotoxic and lead to undesired mutations [6].
Conventional gene targeting efficiencies have also been
significantly improved by the introduction of recombinant
Adeno-associated virus (rAAV) mediated delivery of targeting
constructs. AAV is a single stranded DNA virus that, in
recombinant form, can efficiently deliver a targeting construct to
nuclei of a broad range of target cells [2,7,8]. rAAV targeting
vectors typically have small homology arms that can be easily
assembled by PCR-based methods [9]. Although rAAV transduc-
tion still leads to frequent random integration, targeting frequen-
cies of up to ,1% of transduced cells can be achieved by this
method [7]. Typically, transduced clones are selected based on
acquired resistance to drugs, allowing clonal expansion in culture
of positive clones. However, both targeted clones as well as
frequent random integration events of the drug resistance cassette
are selected by this method, requiring extensive screening to
identify targeting events. Targeting frequencies can be further
improved by specific vector design. For instance promoter-trap or
ATG-trap constructs will express the selectable marker only upon
integration into an expressed gene [7,10] which will often favor
selection of correctly targeted clones.
Tagging of proteins with fluorescent proteins has revolutionized
cell biology, allowing assessment of protein localization and
dynamics in living cells [11]. However, in the majority of cases
fusion proteins are overexpressed from constitutive promoters,
casting doubt on the physiological relevance of the observed
phenomena. These problems are in part ameliorated by the use of
BAC transgenesis that mimics endogenous expression although
still providing the gene of interest in an ectopic copy and in a
foreign chromatin context [12,13]. We developed a protocol that
will allow rapid generation and isolation of human cell clones
expressing fluorescent fusion proteins from endogenous loci with
minimal perturbations of endogenous gene function. Key to this
method is to employ the fluorescence produced by successful
targeting as a means of selection of those clones which we term
FASTarget (Fluoresence Activated Sorting of Targeted clones).
We apply this method to tag or delete the human centromeric
histone CENP-A (centromeric protein A) in both transformed as
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lines.
Results
Rationale and experimental design
Existing strategies for gene targeting in human cells often
require drug selection and clonal outgrowth of selected clones.
Typically, drug resistance does not discriminate between targeting
events and random integration. We set out to develop an approach
to avoid these drawbacks. The method is based on the use of
rAAV vectors [2,14] that feature yellow fluorescent protein (EYFP)
as the only foreign DNA to be introduced into target cells flanked
by short ,1 kb homology arms. EYFP is included as a promoter-
less and ATG-less (ORF-trap) construct which will result in
expression only upon in-frame integration within an expressed
gene. This requirement is expected to select against random
integration events and will strongly favor correct gene targeting
events (Figures 1A and S1). Importantly, EYFP is used as a means
for direct selection of targeted clones obviating the need for time
consuming outgrowth of drug resistant clones. Cells are selected
within days of infection by two rounds of high stringency
fluorescence activated cell sorting (FACS) followed by direct
inspection of individually sorted clones by microscopy (Figure 1B).
This latter step avoids the need for PCR-based methods as a first
means of screening for targeting events.
We designed a compact targeting construct consisting of a
ATG-less EYFP-tag (carrying a 66His-26Prescission tag up-
stream of EYFP that functions as a linker as well as a protease
separable affinity tag [15]) flanked by homology arms that, upon
correct targeting, fuses EYFP to the last coding exon of the
centromeric histone H3 variant CENP-A (see Figure S1 for
sequence details). This gene is encoded by a small 5 exon gene on
chromosome 2. The resulting knockin extends the last coding exon
with EYFP, fully recapitulating the downstream stop codon and
39UTR sequences (Figures 1A and S1). CENP-A is a protein with
a relatively low abundance allowing us to assess the sensitivity of
this methodology. Importantly, functional CENP-A protein
localizes in a stereotypical manner to centromere foci [16] that
can be easily distinguished by fluorescence microscopy providing a
means for visual screening of clones.
FACS-mediated selection of EYFP knockin clones
We infected either untransformed hTERT-immortalized retinal
pigment epithelial (RPE) cells or HeLa cells, a commonly used
cancer cell line, using low-titer rAAV vector particles directly from
crude packaging cell lysates (see methods). Following four days of
non-selective expansion post infection, cells were sorted for rare
acquired EYFP fluorescence (Figure 2A). This sorted population,
enriched 3.000–10.000 fold for YPF positive cells, was further
expanded for 7 days. At this stage a large proportion of cells
expressed EYFP fluorescence (11% and 41% for RPE and HeLa
cells respectively). Optionally, at this point the mixed population
can be scored for targeting by PCR or by visual inspection
(Figure 1B, asterisk). Therefore, potential success can be
determined as early as ,12days after infection. Cells are then
re-sorted individually into 96 well plates. Following expansion,
monoclonal lines were directly scored for correct EYFP centro-
mere localization by fluorescence microscopy. In this way we
found that 94% of recovered RPE clones (44/47) displayed
centromeric EYFP fluorescence which was confirmed by PCR
genotyping and Western blotting (Figures 2B and 3). Thus,
without any prior drug selection we obtained a near homogenous
pool of gene targeted cells demonstrating the combined selective
power of the vector design and FACS mediated selection of clones.
Although targeting in HeLa cells occurred at lower frequencies
(10% (5/48)), correctly targeted clones could be readily isolated
(Figures 2B, 3B and C).
Gene disruption by FASTarget
Given the applicability of the FASTarget strategy to create
knockin clones we reasoned the same approach might facilitate the
generation of gene knockouts. Structure-function analysis of
CENP-A has shown that a region encompassing loop1 and the
alpha-2 helix of the CENP-A histone fold domain are essential for
CENP-A function [17,18]. Removal of this region results in the
loss of approximately two-thirds of the entire histone fold resulting
in a non-centromere localized non-functional truncated protein.
We aimed at deleting the exons encoding this region (3 and 4) and
replacing them with the ORF encoding EYFP placed in frame
with the endogenous ORF, thereby driving EYFP expression from
the endogenous promoter (Figures 4A and S2). In this case, we
included loxP sites just upstream and downstream of the EYFP
coding sequences allowing optional Cre mediated excision and
EYFP recycling for serial targeting. Targeting of this construct
results in a premature stop codon that is predicted to trigger non-
sense mediated decay of the transcript [19]. To avoid this we
introduced an SV40 poly adenylation signal immediately down-
stream of the novel stop codon. Following infection and two
rounds of FACS isolation (Figure 4B), monoclonal hTERT-RPE
lines were screened for targeting by PCR. Targeted deletion of
CENP-A was detected in 3 out 96 clones (3%). The resulting
fluorescent gene product failed to localize to centromeres
indicating successful abrogation of CENP-A gene function
(Figure 4C). Moreover, correct deletion of targeted exons was
confirmed by PCR and the appearance of a truncated CENP-A
protein by immunoblot in which the non-functional N-terminal
tail is fused to EYFP (Figures 4D and E). Deletion of CENP-A
genomic sequences was successful albeit at lower frequencies,
consistent with earlier observations that removal of sequences is
less favorable than inserting DNA [20].
Discussion
Fluorescently tagged proteins are widely used in cell biology to
determine localization and protein dynamics in living cells [11]. A
major caveat is the use of force expression of tagged proteins from
ectopic plasmids or from stable integrations of cDNA constructs
driven by viral promoters. This raises the concern for potential
artifacts affecting protein localization and dynamics. Physiological
expression of tagged proteins is essential to properly assess their
role in cellular processes. Homologous recombination of exoge-
nous sequences into target genomes allows for the introduction of
highly selective genetic changes that include gene knockouts as
well as knockin of point mutations or tags. While the efficiency of
conventional gene targeting is inherently low we present an
approach that allows for rapid and efficient isolation of targeted
cell clones.
Selectivity and speed are achieved by combining two specific
advances. First, a targeting construct is used that features a
promoter-less, ATG-less selection cassette (ORF-trap). In this way,
expression depends on in-frame integration of the expression
cassette into an active gene. While dependent on target gene
expression, this feature selects against random integration events
and favors correct gene targeting events. In principle, an ATG-
trap construct containing a start codon (but no promoter) would
suffice. In that case expression upon random integration will occur
only upon integration upstream of the first coding exon of an
Fluorescence-Based Gene Targeting
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employing the fluorescence gained as a result of gene targeting and
use it as a means to select cells by FACS within days of targeting
construct delivery. This avoids several weeks of drug selection to
obtain resistant clones.
Fluorescent reporters as a means for selection have been used
before in gene targeting experiments [21,22]. We now improve on
this by employing an ORF-trap in combination with fluorescent
proteins to efficiently generate both knockout and functional
knockin clones in both transformed (HeLa) and non-transformed
genomically stable human RPE cell lines. Importantly, when
generating functional knockin clones not only fluorescence but also
correct localization is used as a means for selection of targeted
clones. The histone H3 variant CENP-A, targeted in this study,
localizes in a highly stereotypical manner. This allows for direct
microscopy-based screening rather than by PCR to identify
targeted clones. This approach is applicable in cases in which a
scorable subcellular localization is expected. When this is not the
Figure 1. FASTarget rational and experimental outline. (A) Targeting strategy using ATG-less (ORF-trap) EYFP cassette. Genomic structure of
the CENP-A locus is outlined. Coding exons in light blue, UTRs in dark blue. Targeting construct is placed within rAAV inverted terminal repeats (ITR)
required for transduction. Regions of homology are indicated in beige. Upon targeting the ATG-less EYFP is placed in frame with the last codon of the
CENP-A gene resulting in a CENP-A-EYFP knockin driving EYFP fluorescence from the endogenous CENP-A promoter. Random integration will likely
result in a failure to express EYFP due to the lack of a nearby promoter or out of frame fusion. (B) Schematic and time-line for rAAV production,
transduction, enrichment and purification of targeted clones. Following initial enrichment and expansion cells can be screened as a polyclonal pool
by PCR or microscopy to verify (*) presence of targeted cells.
doi:10.1371/journal.pone.0032646.g001
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the knockout approach described here. Although relatively high
frequencies were obtained in targeting CENP-A using a knockin
construct (up to 94%), this frequency is likely to vary for different
genes depending on DNA sequence and chromatin context. An
important parameter is the extent of sequence homology and
potential interruptions by SNPs [23]. For instance, in the case of
the CENP-A gene, the two alleles in hTERT-RPE differ at 9
positions [single of other simple nucleotide polymorphisms (SNPs)]
that are scattered across both homology arms which is predicted to
affect targeting efficiency. For this reason, to obtain best results, we
sequenced endogenous loci to be targeted and ensure that
targeting constructs match the genotype of the target cell line.
We have shown here how gene function can be disrupted by in-
frame fusion of YFP to a portion of the protein while deleting
essential domains. In principle, homozygous deletions can be
obtained by recycling of the YFP selection cassette. Our knockout
construct is designed such that YFP, fused in frame with the first
two exons of CENP-A is flanked by two loxP sites (Figures 4 and
S2) that can be removed by Cre expression. Clones in which YFP
is removed can be recovered by FACS. Once YFP-negative clones
are isolated and re-grown these can be retargeted bearing in mind
possible SNPs between the first and second allele. We expect this
procedure to add an additional 2.5 months in order to obtain a
double targeted cell line. In summary, we present an improved,
rapid FACS-based method that generates functional genomically
Figure 2. FACS-based strategy to isolate fluorescent knockin clones. (A) Targeting of CENP-A-EYFP knockin construct into human hTERT-RPE
or HeLa cells. FACS profiles of the 1
st (enrichment) and 2
nd (purification) runs are shown. Gates used to collect EYFP positives are shown. Number of
cells collected per total number of cells analyzed is indicated for each run. (B) Live cell differential interference contrast (DIC) and epifluorescent
(EYFP) image is shown for representative monoclonal isolates for hTERT-RPE (top) and HeLa (bottom). (C) FACS profiles of parental (non-EYFP
fluorescent) hTERT-RPE and HeLa cells with gate setting used for purification-mode sorting of rAAV infected cells. Positive hits detected under these
conditions represent background fluorescence.
doi:10.1371/journal.pone.0032646.g002
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Materials and Methods
Gene cloning
A CENP-A-EYFP knockin construct was built by replacing GFP
with a PCR generated EYFP (carrying citrine and monomeriza-
tion mutations: Q69M, A206K) fragment lacking the ATG start
codon into the BspEI and XbaI sites of pIC111 [15]. A 59
homology arm was generated by PCR that covers the CENP-A
locus from 43 bp upstream of exon 2 to the last codon of CENP-A
in exon 4 spanning a total of 1189 bp. This fragment was cloned
as a NheI-SacII containing fragment carrying a NotI site just 39
from the NheI site. The 39 homology arm was designed such to
reproduce the endogenous CENP-A stop codon and cover the
Figure 3. PCR screening and Western verification of EYFP-knockin clones. (A) Schematic outlining PCR screening strategy. Grey regions
indicate sequences outside the targeting construct. A primer set in which one primer complementary to a region outside the targeting construct and
one primer inside the targeting construct (EYFP) was used to amplify a 2088 bp fragment unique to targeted clones. 47 monoclonal lines produced in
the pipeline outlined in Figure 1B were screened for targeting. Water and a previously targeted HeLa clone (c+) were used as negative and positive
clones respectively. (B) PCR verification of targeting. Representative clones are shown in which the left and right flanks are amplified using primer set
in which one primer anneals outside the targeted area and one to EYFP sequences. Sizes of marker fragments (M) and of expected products are
indicated. WT, wild type uninfected parent cells. KI, knockin clones. Asterisks indicate non-specific background products (C) Wild type hTERT-RPE or
HeLa or targeted knockin clones were processed for SDS-PAGE and immunoblotting with an anti-CENP-A antibody revealing novel high molecular
weight CENP-A-EYFP fusion protein in targeted clones only. Proteins from both the targeted CENP-A-EYFP and untagged CENP-A alleles are detected.
doi:10.1371/journal.pone.0032646.g003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32646Figure 4. FACS-based strategy to generate a CENP-A knockout allele. (A) Schematic to scale outlining targeting strategy. Correct targeting
of the rAAV transduced construct results in the in-frame fusion of EYFP after the first codon of exon 3 and the deletion of the remainder of exon 3 and
exon 4. polyA: SV40 poly adenylation signal. (B) Targeting of CENP-A-EYFP knockout (CAtail-EYFP) construct into human hTERT-RPE cells. FACS
profiles of the 1
st (enrichment) and 2
nd (purification) runs are shown. Gates used to collect EYFP positives are indicated. Number of cells collected per
total number of cells analyzed is indicated for each run. (C) Live cell differential interference contrast (DIC) and epifluorescent (EYFP) image is shown
for a representative monoclonal isolate. Note the loss of centromeric signal and resulting diffuse nuclear EYFP fluorescence. (D) PCR verification of
CENP-A knockout. Left and right flanks were analyzed analogous to Figure 3B. Right panel (across): A PCR using two primers flanking the targeted
domain resulting in the amplification of both the targeted knockout allele (KO) as well as the untargeted wild type allele (WT). Sizes of marker
fragments (M) and of expected products are indicated. All primer numbers correspond to those listed in methods (E) Immunoblot showing targeted
Fluorescence-Based Gene Targeting
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of exon 5 spanning a total of 1275 bp. This fragment was cloned
as an XbaI fragment carrying a NotI site just 59 from the end of
the right arm. The entire cassette was transferred as a NotI
fragment into the corresponding site of pAAV-LacZ [14],
replacing the LacZ cassette and inserting the CENP-A-EYFP
targeting construct in between the rAAV inverted terminal repeats
(ITR) (See Figure S2 for detailed schematic). Targeting results in
the formation of a 46.3 kDa fusion of the 66His-26Prescission-
EYFP tag (LAP-tag [15]) to the last amino acid of CENP-A.
For generation of the CENP-A knockout construct, EYFP
(Q69M, A206K) lacking the ATG codon was placed between loxP
sites in identical orientation. The 59 homology arm covers the
CENP-A locus from 367 bp upstream of exon 2 and ending just
downstream of the 1
st codon in exon 3 spanning a total of 996 bp.
The 39 homology arm was placed immediately downstream of the
39 loxP site which includes the endogenous CENP-A stop codon in
exon 4 and reproducing the 39UTR and part of exon 5 through
1067 bp downstream of the CENP-A stop codon. A PCR
generated 251 bp SV40 polyadenylation sequence from pEYFP-
N1 (Clontech) was inserted into the unique SacI site just
downstream of the CENP-A stop codon (See Figure S2 for
detailed schematic). Targeting results in the insertion of a loxP
encoded linker fused to EYFP that is in turn fused to the first
codon of exon 3 and the deletion of the remaining CENP-A
coding sequences. This results in the production of a 36.8 kDa
protein in which the first 70 amino acids of CENP-A (CAtail) are
fused to EYFP.
Cell Culture
HeLa cells (gift from Don Cleveland [24]) and their derivatives
were cultured in DMEM medium supplemented with 10% heat
inactivated newborn calf serum at 37uC5 %C O 2. hTERT-RPE
(gift from Prasad Jallepalli [14]) were cultured in DMEM-F12
medium supplemented with 10% heat inactivated fetal bovine
serum and 0.348% Sodium Bicarbonate at 37uC 5%CO2. Cells
were passaged by a single wash in D-PBS and harvested by
trypsinization in 16TrypLE Express. All Cell culture reagents are
from Gibco.
rAAV production and infection
Targeting constructs are packaged into rAAV particles as
described [14]. One day before infection, 1 million RPE-hTERT
or HeLa cell lines were seeded in T75 flasks. 48 h after infection
excess rAAV particles were removed and cells were expanded for
another 2 days before sorting.
Flow cytometry
rAAV infected or uninfected controls were resuspended in ,2–
4 ml/T75 flask ice cold filter sterilized (0.2 mm) D-PBS supple-
mented with 5% BSA. Cell aggregates were removed by passage
over a 0.45 mm mesh by gravity flow and kept on wet ice at all
times.
Cells were sorted on a MoFlo (Beckman Coulter, USA), using a
100 mm nozzle at 206.8 kPa (30 psi) and ,39 kHz Drop Drive
frequency. A 488 nm air-cooled Coherent Sapphire 488-200
CDRH laser (140 mW output) was used for forward and side
scatter as well as autofluorescence measurements. EYFP excitation
was achieved with a Coherent Innova I90C Argon laser set at
514 nm (220 mW output). Forward scatter was used as trigger and
EYFP emission was detected using a 550/30 band-pass emission
filter. EYFP (550/30) versus autofluorescence (580/20) signals are
plotted defining the autofluorescent ratio. Cells deviating from this
correlation in the EYFP channel are scored as EYFP positive. In
addition, non-fluorescent cells were used to define the EYFP gate
(Figure 2C).
Cells were sorted in ‘‘enrich mode’’ and collected into ,4m lo f
ice cooled collection medium (DMEM/F12 full (Gibco) medium
consisting of 50% fresh and 50% conditioned medium (harvested
from log phase growth cells and 0.2 mm filtered). Heat inactivated
FBS (Gibco) and Fungizone [Amphotericin B (Invitrogen)] were
added to a final concentration of 20% and 2.5 mg/ml respectively.
Cells were expanded for 7 days and re-sorted as described above
except in ‘‘single-cell mode’’ directly into 96-well plates containing
150 ml ice cold collection medium. Gates were set to include false
positive hits during the first sorting to enrich for cells with, a priori
unknown fluorescent intensities. Gates were set more conserva-
tively during the second sorting run to purify positive clones.
Single clones were expanded for 10–20 days.
Microscopy
To screen for targeting, cells were either transferred to 8 well
chambered cover glasses (Lab-Tek) for direct inspection of live
cells or onto 12 mm coverslips in 24 well plates, cultured for
24 hours followed by fixation with 4% formaldehyde (Thermo
Scientific) for 10 min, permeabilized twice in PBS supplemented
with 0.1% triton for 5 minutes and stained with DAPI (Sigma)
before mounting in Mowiol (Calbiochem). Digital images were
captured using a DeltaVision Core system (Applied Precision) that
controls an inverted microscope (Olympus, IX-71), coupled to a
Cascade2 EMCCD camera (Photometrics). 5126512 images were
collected at 16 binning using a 1006 oil objective (NA 1.40,
UPlanSApo) with 0.2 mm z sections scanning the entire nucleus.
Maximum intensity projections were generated in softWoRx
(Applied Precision).
PCR screening
Cells were harvested by trypsinization and lysed in TNES buffer
(10 mM Tris (pH 7.4), 100 mM NaCl, 10 mM EDTA, 0.5%
SDS, 100 mg/ml RNase A (Invitrogen)) and incubated for
10 minutes at ambient temperature. DNA was extracted by
phenol/chloroform extraction followed by chloroform extraction.
Aqueous phase was supplemented with NaOAc to a final
concentration of 300 mM and DNA was precipitated with 2
volumes of ethanol, washed in 70% ethanol and resuspended in
10 mM Tris (pH 8), 0.1 mM EDTA.
For PCR a 12.5 ml reaction was assembled containing 16.6 mM
Ammonium Sulfate, 67 mM Tris (pH 8.8), 6.7 mM MgCl2,
10 mM Beta Mercaptoethanol, 6% DMSO (Sigma), 1.2 mM
dNTPs (Fermentas), 10 pmoles of each primer (Sigma), 1 unit of
Dream Taq (Fermentas) and ,200 ng genomic DNA. Reaction
was thermo cycled using the following (touchdown) parameters:
94uC, 30 s for 1 cycle; 94uC, 15 s, 63uC for 30 s, 70uC for 2 min
(4 cycles); 94uC for 15 s, 60uC for 30 s, 70uC for 2 min (4 cycles);
94uC for 15 s, 57uC for 30 s, 70uC for 2 min (40 cycles); 70u for
6 min; 8uC ‘. Primers used: 1:AGGTGCCTGACACTGA-
CACTGAG, 2:GGGGTAGCGGGCGAAGC, 3:CTGAGCAA-
AGACCCCAACGAGAAG, 4:CAGTATAATCTCTATCTGT-
AACAGTAAGTCC, 5:GCTCCTCGCCCTTGCTCAC, 6:AG-
CENP-A knockout clone and parental wild type hTERT-RPE cells. Anti-CENP-A antibody reveals a novel high molecular weight species in which a 70
amino acid N-terminal fragment of CENP-A is fused to EYFP (CAtail-EYFP).
doi:10.1371/journal.pone.0032646.g004
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annotation of primer numbers).
Immunoblotting
Extracts of ,10
5 HeLa or hTERT-RPE cells were separated in
an 11% SDS-PAGE gel and transferred to a PVDF membrane.
Blots were probed with rabbit anti-human-CENP-A (Cell
Signaling #2186) at a dilution of 1:500. Anti-rabbit HRP-
conjugated secondary antibodies were purchased from Jackon
Immunoresearch Laboratories.
Supporting Information
Figure S1 Nucleotide level schematic of CENP-A-YFP
knockin targeting vector. Inverted terminal repeats (ITR) of
the pAAV vector are partially shown. Regions of homology to the
CENP-A locus and the YFP containing LAP (6XHIS-PreScission-
EYFP) cassette are cloned into NotI sites, internal of the ITRs.
Relevant junctions and continuation of reading frame between
target locus and the targeting construct are indicated. Nucleotide
positions are indicated as a reference for size of the construct.
(TIF)
Figure S2 As Figure S1 but details for CENP-A knockout
(CAtail-YFP) targeting vector are shown. In this case a
recyclable loxP-EYFP-loxP cassette is used and targeted in frame
with the first amino acid of exon 3, deleting all downstream coding
sequences. PolyA: SV40 polyadenylation signal.
(TIF)
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